Cancer Cachexia: Mechanisms and Clinical Implications

Cancer cachexia

(2010) Michael J Tisdale   CURRENT OPINION IN GASTROENTEROLOGY

Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference

(2010) Thomas Kung et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia

(2010) G. Mantovani et al.   ONCOLOGIST

The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer

(2009) D A C Deans et al.   BRITISH JOURNAL OF CANCER

Systemic inflammation, nutritional status and survival in patients with cancer

(2009) Donald C McMillan   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)

(2009) Aminah Jatoi et al.   LUNG CANCER

Update on melanocortin interventions for cachexia: Progress toward clinical application

(2009) Mark Daniel DeBoer   NUTRITION

Mechanisms of Cancer Cachexia

(2009) Michael J. Tisdale   PHYSIOLOGICAL REVIEWS

Estimation of Cachexia among Cancer Patients Based on Four Definitions

(2009) Kathleen M. Fox et al.   Journal of Oncology

Cachexia: A new definition

(2008) William J. Evans et al.   CLINICAL NUTRITION

Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue

(2008) Florian Strasser   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer

(2008) Jeannine Bachmann et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results

(2008) Giovanni Mantovani et al.   NUTRITION

The potential and the pitfalls of β-adrenoceptor agonists for the management of skeletal muscle wasting

(2008) James G. Ryall et al.   PHARMACOLOGY & THERAPEUTICS

An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer

(2008) Donald C. McMillan   PROCEEDINGS OF THE NUTRITION SOCIETY

A randomized, double-blind, placebo-controlled trial of a β-hydroxyl β-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)

(2008) Lawrence Berk et al.   SUPPORTIVE CARE IN CANCER

C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort

(2007) C. Marsik et al.   CLINICAL CHEMISTRY

Central blockade of melanocortin receptors attenuates the metabolic and locomotor responses to peripheral interleukin-1β administration

(2007) Keith W. Whitaker et al.   NEUROPHARMACOLOGY